on 20 Apr 2023
Last Applicant/ Owned by
Acuitas Therapeutics, Inc.
6190 Agronomy Rd Suite 405, University of British Columbia
Vancouver BRITISH COLUMBIA, , V6T1W5
Serial Number
UK00003902781 filed on 20th Apr 2023
Registration Number
UK00003902781 registered on
22nd Sept 2023
Correspondent Information
Grünecker
The Clubhouse, 20 St Andrew Street
London,
EC4A 3AG
Lipids, lipid nanoparticles, lipid formulations, and nucleic acids, messenger RNA, for scientific purposes, research purposes, or laboratory use.
Pharmaceutical preparations, such as, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics; pharmaceutical preparations comprised of nucleic acids, messenger RNA, and lipid nanoparticles; pharmaceutical preparations comprised of lipid nanoparticles; pharmaceutical preparations, such as, vaccines for human use; pharmaceutical preparations for gene silencing, for gene editing, for antibody therapeutics, for protein replacement therapeutics, and for nucleic acid therapeutics.
Research, development, and evaluation services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; synthetic chemistry services, such as, design, synthesis, analysis, evaluation, and biophysical characterization of lipids, lipid formulations, and lipid nanoparticles; preclinical study services, such as, conducting pharmacodynamic and pharmacokinetic studies, safety and tolerability studies regarding clinical pathology and histopathology, immune response characterization studies, and bioanalytical services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, messenger RNA, drug delivery agents, and nucleic acid therapeutics; clinical research services, such as, chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries; research and development of new formulation products for others; research and development of new pharmaceuticals, medical therapies, vaccines, gene therapies, drug delivery agents, and nucleic acid therapeutics for others; project management services for research and development programs in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology.
Regulatory compliance consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid nanoparticles, nucleic acid,messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology.
UK00003902781
Figurative
Individual